Skip to content

State of the Union Offers Encouraging News for Research

In his State of the Union address last night, President Obama urged Congress to invest in critical priorities, reorganize the government, and begin addressing growing debt and deficits in order to ensure US success in the future. Obama proposed increased spending on education, infrastructure, and research and technology — particularly clean energy technology — that the President said would both create jobs and enhance US competitiveness in the world.

 “We need to out-innovate, out-educate, and out-build the rest of the world,” he said. “We have to make America the best place on Earth to do business. We need to take responsibility for our deficit, and reform our government. That’s how our people will prosper. That’s how we’ll win the future.”

The promise of technology heavily underpinned the President’s address, as he emphasized the importance of clean tech, broadband, and science education in achieving his goal. He made the case for continued investment in research funding, and a renewed commitment to immigration reform that’s designed to keep talented foreign workers in the country.

While this all sounds encouraging for the research and higher education communities, the President proposes to pay for those investments by cutting other domestic programs.  He is proposing a five-year freeze on non-security discretionary spending, which he said would save more than $400 billion over 10 years and bring discretionary spending to the lowest level as a share of the economy since the Eisenhower administration. It remains to be seen whether the President can actually motivate Congress into acting on his proposals, some of which appeared in Obama’s prior State of the Union addresses. It was in 2010 that the president sounded similar notes on innovation, taxes and trade, but those reforms often lagged in a Congress more focused on other big-ticket items like healthcare.

One surprise in the President’s address was his threat to veto any legislation that includes earmarks, essentially closing the door on any earmarks for FY12. Democrats in the Senate denounced the President’s call as a power grab that will have little-to-no impact on the federal budget deficit.

But the reality is that Democrats face a political climate that makes it virtually impossible to get any earmarks through this Congress if Obama and Republicans in congress maintain their opposition. Speaker John Boehner (R-OH) has already said that no appropriations bills with earmarks will pass the House, and Senate Republicans have also embraced a moratorium on the pet projects. That means House Republicans, Senate Republicans, and the President would have to cave in if any earmarks are to become law this year.

In other budget news, the House Republicans on Tuesday moved forward in their push to sharply reduce spending and draw contrasts with President Obama’s budget priorities. They adopted a resolution calling for non-security discretionary spending to be cut to FY08 levels or less for the last seven months of FY11. House Republican leaders also announced that they are planning to bring a government funding measure to the floor the same week the president is expected to release his budget (week of February 14th). During that same week, the House will also consider another stopgap spending measure to fund the government for the remainder of FY11. The current stopgap funding expires March 4th.

The Office of Federal Relations is closely monitoring all of these events and will provide additional information on this site as it becomes available. In the meantime, we are anticipating major programmatic cuts in the President’s FY12 Budget and are currently developing materials to defend those federal programs that the UW works with the most.

Judge: Federal Government Cannot Fund Embryonic Stem Cell Research

On Tuesday, Federal District Court Judge Royce C. Lamberth issued a preliminary injunction which prohibits the federal government from funding any and all human embryonic stem cell research citing a pending lawsuit that contends that embryonic stem cell research violates the so called Dickey-Wicker provision. The Dickey-Wicker provision bars funding for “research in which a human embryo or embryos are destroyed, discarded, or knowingly subjected to risk of injury or death greater than that allowed for research on fetuses in utero research”.

NIH Director Francis Collins provided details of the impact of the ruling, based on an interpretation by the Department of Justice. According to Dr. Collins, ongoing research (totaling around $131 million) that has already been funded will continue, undisrupted, until it reaches the point of renewal. Projects that are in review, even if they have been scored, or that are up for renewal, will be halted immediately, and applications will no longer be reviewed. NIH has also ceased reviewing applications for new embryonic stem cells lines. It remains unclear whether no-cost extensions of existing ESC projects would be allowed.

In addition to the problem presented by Dickey-Wicker, AAU is concerned about the findings related to the competitive status of the two adult stem cell researchers serving as plaintiffs in this case. The researchers were granted standing on the basis that they must compete for funds with ESC researchers. Judge Lamberth’s ruling goes a step further by declaring that these researchers suffer irreparable harm due to this competition. (He also determined that blocking federal funding would not do irreparable harm to ESC researchers.) This could have far-reaching – although not immediate – implications for all federally-funded peer-reviewed research, as it could effectively empower any researcher to sue a research agency over “unfair competition”.

Read the entire decision made by the Court

NIH Changes to Conflict of Interest Policy

The National Institutes of Health (NIH) published in the Federal Register on Friday, May 21, 2010 a Notice of Proposed Rulemaking (NPRM) outlining new Responsibility of Applicants for Promoting Objectivity in Research for which Public Health Service Funding is Sought and Responsible Prospective Contractors – NIH’s Financial Conflict of Interest policy (75FR 28688).   The text of Federal Register notice  is also available on the NIH conflicts of interest website.  Comments are due July 21, 2010.  This long anticipated proposed rule is a result of NIH’s consideration of the comments it received on the Advanced NPRM in May 2009.  The description of the proposed revisions (Section II of the Supplemental Information in the Register notice) addresses the responses NIH received to the Advanced NPRM. 

There are substantive and significant changes being proposed by NIH.  Some of those changes have been anticipated by the research community; others have not.  Some of the changes will require changes in how many research organizations have designed and implemented the current NIH requirements; others will not.  It is important to remember that the proposed policy is NIH’s requirement and sets a minimum set of standards.  Organizations can implement policies the meet and exceed these requirements.  The reference to “minimum standards” is not to suggest that the current NIH policy is insufficient in achieving the goal of objectivity.  Rather, it is to remind organizations of how NIH views the reporting requirements – for purposes of reporting to NIH and – under the proposed rule – posting to public websites, organizations must report on financial conflicts of interest (FCOI) according to the organization’s standards, if they are different.   For example, the proposed rule lowers the threshold for a “significant financial interest” from $10,000 or equity interests of 5% to $5,000 total value in remuneration and/or equity in a publically traded company.  If the organization sets a $0 value, the organization must report and post interests from $0.   Continue reading “NIH Changes to Conflict of Interest Policy”

NIH Addresses Funding “Cliff”

Yesterday, the National Institutes of Health director told Senate appropriators that the agency’s funding will face a “cliff” in FY11 when a two-year allocation of $10.4 billion in stimulus money for research runs out.  NIH Director Francis Collins also told committee members that during the past 30 years NIH grant applicants had a 25 percent to 30 percent chance of success at obtaining funding. That level has now slipped to 21 percent and is expected to fall even further to about 15 percent in FY11 as the flow of money provided through the economic stimulus law ends. 

President Obama requested $32 billion for NIH in his FY11 budget, an increase of 3.2 percent. The boost matches the inflationary index for biomedical research. While several members of the committee voiced strong support for the agency’s request they also said the challenging fiscal environment would make it difficult to secure a larger increase than is called for under the President’s proposal.

Senator Arlen Specter (D-PA), a long-time champion for NIH funding, pressed for more funding and called the proposed 3.2 percent boost “disgraceful.”  Specter suggested that scientists should become stronger advocates for NIH funding by highlighting how the stimulus funding has helped spark more interest in biomedical research.  Senator Harkin (D-IA), Chair of the Senate Appropriations Subcommittee on Labor, HHS, and Education, also expressed support for NIH funding but reminded committee members that finding additional funding will be difficult this year.

NIH and NSF Announce New Research Programs

The National Institutes of Health (NIH) and National Science Foundation (NSF) have jointly announced two new research grant programs to bridge the sciences: New Biomedical Frontiers at the Interface of the Life and Physical Sciences (R01)  and Transforming Biomedicine at the Interface of the Life and Physical Sciences (R01) PAR-10-141. The former focuses on basic research and the latter on clinical and translational research.

The purpose of these two programs is to provide support for cutting-edge, visionary research, only possible through cross disciplinary research. Breakthroughs such as x-ray crystallography, CAT scans, and magnetic resonance imaging have had an enormous and important effect on biology. These discoveries were funded by sources, such as the Bell Labs, which are no longer in existence. Thus, it is very difficult for researchers to work on similar breakthrough technologies today.

Both programs will provide grants of varying sizes and lengths to accommodate a variety of research, encourage young investigators with novel ideas to apply, and will be reviewed by special review panels that include reviewers from the physical, mathematical, and computational sciences selected by NSF.  Applications will be accepted once a year in May through 2012.  The first deadline is May 18, 2010.